Find your next paid study

The Hospital for Sick ChildrenNCT04929899

Actual pay is set by the research site.

Observational

STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy

To learn if monitoring blood levels of heart injury (troponin levels) in cancer participants treated with immune checkpoint inhibitors will lead to decreased h…

Immune Checkpoint Therapy

M.D. Anderson Cancer CenterNCT06337097

Actual pay is set by the research site.

Leveraging the Exposome and Patient Sensor Data to Enhance Personalized Diabetes Care Across Diverse Communities

The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, per…

Type 2 Diabetes

University of Illinois at ChicagoNCT06989008

Actual pay is set by the research site.

Graft Vs Host DiseaseGraft-versus-host-diseaseGraft Versus Host Disease

An Open-Label Phase I Study of JAK Inhibitor Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Allogeneic hematopoietic cell transplantation (HCT) is one of the only curative intent therapies available for hematologic malignancies. HLA-matched sibling do…

Washington University School of MedicineNCT06008808

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

This study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole vers…

Breast Cancer

Hoffmann-La RocheNCT06790693

~$50 – $2,250

Actual pay is set by the research site.

AL AmyloidosisAmyloidosis

A Dose-Finding and Proof-of-Concept Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

The goal of this study is to test the safety of drug, Belantamab Mafodotin, and see what effects (good and bad) it has on people who take it and have amyloidos…

University of Texas Southwestern Medical CenterNCT05145816

~$150 – $3,000

Actual pay is set by the research site.

Observational

Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (Pilot)

One of the most common and widely disseminated trauma treatments is Trauma Focused Cognitive Behavioral Therapy (TF-CBT). TF-CBT is a therapist-led, structured…

TraumaPosttraumatic Stress Disorder

The University of Texas Health Science Center, HoustonNCT07396935

Actual pay is set by the research site.

Observational

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, sympto…

Relapsed Adult AMLPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia

Massachusetts General HospitalNCT05237258

Actual pay is set by the research site.

The DETECT Study - Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons: Tampon and Tissue Sampling to Evaluate Markers for Detection of Endometrial and Ovarian Cancer

BACKGROUND: Endometrial cancer is a common and deadly cancer for women. It is getting more common and deadly because risk factors like age and obesity are inc…

Endometrial CancerEndometrial Cancer PrecursorsOvarian Cancer+1 more

University of Alabama at BirminghamNCT03538665

Actual pay is set by the research site.

GliomaMalignant Brain NeoplasmMeningioma+1 more

Biologic Validation of Zr-89 Crefmirlimab Berdoxam CD8+ Minibody ImmunoPET in Human Brain Tumors

This phase I trial studies how well zirconium (Zr)-89 crefmirlimab berdoxam and immuno-positron emission tomography (PET) identifies areas of immune cell activ…

Jonsson Comprehensive Cancer CenterNCT06650163

~$150 – $3,000

Actual pay is set by the research site.

Phase 4

Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

Single-center, open label, prospective study conducted at Medstar Georgetown Headache Center. Men and woman ≥ 18 years old that are diagnosed with migraine wit…

MigraineTrigger Induced Migraine

Medstar Health Research InstituteNCT07301008

~$25 – $1,500

Actual pay is set by the research site.

Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects

Our overall objective is to obtain an initial assessment of the potential value of using \[18F\]3F4AP for imaging demyelinating diseases such as multiple scler…

Multiple Sclerosis